BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 11828012)

  • 21. Deletion of the nucleotide excision repair gene Ercc1 reduces immunoglobulin class switching and alters mutations near switch recombination junctions.
    Schrader CE; Vardo J; Linehan E; Twarog MZ; Niedernhofer LJ; Hoeijmakers JH; Stavnezer J
    J Exp Med; 2004 Aug; 200(3):321-30. PubMed ID: 15280420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
    Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
    Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
    Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
    Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells.
    Shin CY; Mellon I; Turker MS
    Oncogene; 2002 Mar; 21(11):1768-76. PubMed ID: 11896608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation.
    Ehrenstein MR; Neuberger MS
    EMBO J; 1999 Jun; 18(12):3484-90. PubMed ID: 10369687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
    Christmann M; Kaina B
    J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair.
    Gu L; Hong Y; McCulloch S; Watanabe H; Li GM
    Nucleic Acids Res; 1998 Mar; 26(5):1173-8. PubMed ID: 9469823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair.
    Tomer G; Buermeyer AB; Nguyen MM; Liskay RM
    J Biol Chem; 2002 Jun; 277(24):21801-9. PubMed ID: 11897781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of DNA-mismatch repair gene expression in oral melanomas.
    Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
    Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunohistochemical detection of mismatch repair gene proteins (MLH1, MSH2, MSH6, and PMS2): practical aspects in antigen retrieval and biotin blocking protocols.
    Manavis J; Gilham P; Davies R; Ruszkiewicz A
    Appl Immunohistochem Mol Morphol; 2003 Mar; 11(1):73-7. PubMed ID: 12610360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.
    Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M
    Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.
    Andrew SE; Xu XS; Baross-Francis A; Narayanan L; Milhausen K; Liskay RM; Jirik FR; Glazer PM
    Carcinogenesis; 2000 Jul; 21(7):1291-5. PubMed ID: 10874005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of DNA mismatch repair genes in naevi.
    Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
    In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
    Wu X; Platt JL; Cascalho M
    Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Homologs of MutS and MutL during mammalian meiosis].
    Santucci-Darmanin S; Paquis-Flucklinger V
    Med Sci (Paris); 2003 Jan; 19(1):85-91. PubMed ID: 12836196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
    Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
    Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells.
    Baross-Francis A; Makhani N; Liskay RM; Jirik FR
    Oncogene; 2001 Feb; 20(5):619-25. PubMed ID: 11313994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different mismatch repair deficiencies all have the same effects on somatic hypermutation: intact primary mechanism accompanied by secondary modifications.
    Kim N; Bozek G; Lo JC; Storb U
    J Exp Med; 1999 Jul; 190(1):21-30. PubMed ID: 10429667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visualization of mosaicism in tissues of normal and mismatch-repair-deficient mice carrying a microsatellite-containing transgene.
    Hersh MN; Stambrook PJ; Stringer JR
    Mutat Res; 2002 Aug; 505(1-2):51-62. PubMed ID: 12175905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.